Literature DB >> 9070877

Overexpression of SAP-1, a transmembrane-type protein tyrosine phosphatase, in human colorectal cancers.

Y Seo1, T Matozaki, M Tsuda, Y Hayashi, H Itoh, M Kasuga.   

Abstract

SAP-1 is a human transmembrane-type protein tyrosine phosphatase that is abundant in colon and pancreatic cancer cell lines. The expression of SAP-1 in surgically excised human colorectal cancer specimens has now been investigated by immunohistochemical staining and in situ hybridization. Normal colon tissue or adenomas with mild dysplasia showed no detectable expression of SAP-1. In contrast, 2 of 17 adenomas with moderate or severe dysplasia and 19 of 48 (40%) adenocarcinomas expressed SAP-1, SAP-1 was localized predominantly to the apical surface of colonic cells in adenoma tissue showing moderate dysplasia, but it was also observed in the cytoplasm and at the basal surface of both adenoma cells showing severe dysplasia and adenocarcinoma cells. In situ hybridization with a SAP-1 antisense RNA probe detected SAP-1 mRNA in 6 of 9 colorectal cancers, but not in the surrounding mesenchymal tissue or normal mucosa. Sequencing of the K-RAS gene revealed that 10 of 15 (67%) SAP-1-positive cancers contained a mutation in codon 12. The serum concentration of carcinoembryonic antigen was normal in approximately half of the patients with SAP-1-positive colorectal cancers. These results suggest that SAP-1 is frequently overexpressed in human colorectal cancers and that such overexpression may occur relatively late in the adenoma-carcinoma sequence.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9070877     DOI: 10.1006/bbrc.1997.6139

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

Review 1.  Inside the human cancer tyrosine phosphatome.

Authors:  Sofi G Julien; Nadia Dubé; Serge Hardy; Michel L Tremblay
Journal:  Nat Rev Cancer       Date:  2011-01       Impact factor: 60.716

2.  Crystal structure of the catalytic domain of human RPTPH.

Authors:  Myeongbin Kim; Seong Eon Ryu
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2022-06-15       Impact factor: 1.072

Review 3.  The impact of phosphatases on proliferative and survival signaling in cancer.

Authors:  Goutham Narla; Jaya Sangodkar; Christopher B Ryder
Journal:  Cell Mol Life Sci       Date:  2018-05-03       Impact factor: 9.261

Review 4.  Protein tyrosine phosphatases: promising targets in pancreatic ductal adenocarcinoma.

Authors:  Mariana Tannús Ruckert; Pamela Viani de Andrade; Verena Silva Santos; Vanessa Silva Silveira
Journal:  Cell Mol Life Sci       Date:  2019-04-13       Impact factor: 9.207

Review 5.  Receptor-type protein tyrosine phosphatases in cancer.

Authors:  Yu Du; Jennifer R Grandis
Journal:  Chin J Cancer       Date:  2014-10-17

6.  Prognostic implication of PTPRH hypomethylation in non-small cell lung cancer.

Authors:  Takashi Sato; Kenzo Soejima; Eri Arai; Junko Hamamoto; Hiroyuki Yasuda; Daisuke Arai; Kota Ishioka; Keiko Ohgino; Katsuhiko Naoki; Takashi Kohno; Koji Tsuta; Shun-Ichi Watanabe; Yae Kanai; Tomoko Betsuyaku
Journal:  Oncol Rep       Date:  2015-06-25       Impact factor: 3.906

7.  Low molecular weight protein tyrosine phosphatase (LMWPTP) upregulation mediates malignant potential in colorectal cancer.

Authors:  Elmer Hoekstra; Liudmila L Kodach; Asha M Das; Roberta R Ruela-de-Sousa; Carmen V Ferreira; James C Hardwick; C Janneke van der Woude; Maikel P Peppelenbosch; Timo L M Ten Hagen; Gwenny M Fuhler
Journal:  Oncotarget       Date:  2015-04-10

8.  Frameshift mutations in coding repeats of protein tyrosine phosphatase genes in colorectal tumors with microsatellite instability.

Authors:  Sebastian Korff; Stefan M Woerner; Yan P Yuan; Peer Bork; Magnus von Knebel Doeberitz; Johannes Gebert
Journal:  BMC Cancer       Date:  2008-11-10       Impact factor: 4.430

9.  Increased PTP1B expression and phosphatase activity in colorectal cancer results in a more invasive phenotype and worse patient outcome.

Authors:  Elmer Hoekstra; Asha M Das; Marloes Swets; Wanlu Cao; C Janneke van der Woude; Marco J Bruno; Maikel P Peppelenbosch; Peter J K Kuppen; Timo L M Ten Hagen; Gwenny M Fuhler
Journal:  Oncotarget       Date:  2016-04-19

10.  Identification of novel regulators of STAT3 activity.

Authors:  Elina Parri; Heikki Kuusanmäki; Arjan J van Adrichem; Meri Kaustio; Krister Wennerberg
Journal:  PLoS One       Date:  2020-03-31       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.